Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov 19;75(22):7519-34.
doi: 10.1021/jo101619d. Epub 2010 Oct 19.

Total synthesis of (+)-nankakurines A and B and (±)-5-epi-nankakurine A

Affiliations

Total synthesis of (+)-nankakurines A and B and (±)-5-epi-nankakurine A

Ryan A Altman et al. J Org Chem. .

Abstract

The first total syntheses of the Lycopodium alkaloids (+)-nankakurine A (2), (+)-nankakurine B (3), and the originally purported structure 1 of nankakurine A were accomplished. The syntheses of 2 and 3 feature a demanding intramolecular azomethine imine cycloaddition as the key step for generating the octahydro-3,5-ethanoquinoline moiety and installing the correct relative configuration at the spiropiperidine ring juncture. The cyclization precursor was prepared from octahydronaphthalene ketone 50, which was assembled from enone (+)-9 and diene 48 by a cationic Diels-Alder reaction. The Diels-Alder reactants were synthesized from 5-hexyn-1-ol (16) and (+)-pulegone (49), respectively. The tetracyclic ring system of 1 was generated using an unprecedented nitrogen-terminated aza-Prins cyclization cascade. The enantioselective total syntheses of (+)-nankakurine A (2) and (+)-nankakurine B (3) establish the relative and absolute configuration of these alkaloids and are sufficiently concise that substantial quantities of 2 and 3 were prepared for biological studies. (+)-Nankakurine A and (+)-nankakurine B showed no effect on neurite outgrowth in rat hippocampal H-19 cells over a concentration range of 0.3-10 μM.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Nankakurines A and B and two structurally related Lycopodium alkaloids.
FIGURE 2
FIGURE 2
Molecular models of low-energy conformations of the most stable disalts of nankakurine B (2); ΔE = E(conf B) – E(conf A) in kcal/mol; energies marked with an asterisk refer to DFT calculations using the COSMO model for methanol solvent.
FIGURE 3
FIGURE 3
1H NMR Spectra of the Titration of Synthetic (+)-2 and (+)-3 with TFA. a Matches 1H NMR of 2 reported in 2004. b Matches 1H NMR of 3 reported in 2006.
FIGURE 4
FIGURE 4
Absence of neurotrophic properties of (+)-nankakurine A (2) and (+)-nankakurine B (3) in rat hippocampus cells; data are expressed as the mean of two separate experiments; control = DMSO; reference = positive reference compound.
SCHEME 1
SCHEME 1
Retrosynthetic Analysis of 5-epi-Nankakurine (1)
SCHEME 2
SCHEME 2
Synthesis of cis-Octahydronaphthalene Amine 22.
SCHEME 3
SCHEME 3
Attempted Nitrogen-Terminated Aza-Prins Reaction of Cyanomethyl Amine 23.
SCHEME 4
SCHEME 4
Attempted Hydroamination of Tricyclic Unsaturated Sulfonamides 24, 25, and 28.
SCHEME 5
SCHEME 5
Potential Nitrogen Participation in the Aza-Prins Cyclization to form Octahydro-3,5-ethanoquinoline 24.
SCHEME 6
SCHEME 6
Attempted Sulfonamide-Terminated Aza-Prins Reaction of Carbamates 37 and 39.
SCHEME 7
SCHEME 7
Sufonamide-terminated Aza-Prins Cyclization to Form Spirotetracyclic Product 27.
SCHEME 8
SCHEME 8
Elaboration of 27 to (±)-5-epi-Nankakurine A (1).
SCHEME 9
SCHEME 9
Retrosynthetic Analysis of (+)-Nankakurines A (2) and B (3)
SCHEME 10
SCHEME 10
Synthesis of cis-Octahydronaphthalene Hydrazine Derivatives 5153.
SCHEME 11
SCHEME 11
Competition Between Intramolecular Azomethine Imine Dipolar Cycloaddition and Aza-Prins Cyclization.
SCHEME 12
SCHEME 12
Completion of the Enantioselective Total Syntheses of (+)-Nankakurine A (2) and (+)-Nankakurine B (3)

Similar articles

Cited by

References

    1. For reviews of the Lycopodium alkaloids, see: Kobayashi J, Morita H. In: The Alkaloids. Cordell GA, editor. Vol. 61. Academic Press; New York: 2005. p. 1.Ma X, Gang DR. Nat Prod Rep. 2004;21:752–772.Ayer WA, Trifonov LS. In: The Alkaloids. Cordell GA, Brossi A, editors. Vol. 45. Academic Press; New York: 1994. p. 233.Ayer WA. Nat Prod Rep. 1991;8:455–463.MacLean DB. In: The Alkaloids. Brossi A, editor. Vol. 26. Academic Press; New York: 1985. p. 241.MacLean DB. In: The Alkaloids. Manske RHF, editor. Vol. 14. Academic Press; New York: 1973. p. 348.MacLean DB. In: The Alkaloids. Manske RHF, editor. Vol. 10. Academic Press; New York: 1968. p. 305.

    1. Hirasawa Y, Morita H, Kobayashi J. Org Lett. 2004;6:3389–3391. - PubMed
    1. Ayer WA, Ball LF, Browne LM, Tori M, Delbaere LTJ, Silverberg A. Can J Chem. 1984;62:298–302.
    1. Hirasawa Y, Kobayashi J, Obara Y, Nakahata N, Kawahara N, Goda Y, Morita H. Heterocycles. 2006;68:2357–2364.
    1. Dawbarn D, Allen SJ. Neuropath Appl Neurobiol. 2003;29:211–230. - PubMed
    2. Dauer W. Science. 2007;411:60–62. - PubMed

Publication types